SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-20-000174
Filing Date
2020-09-24
Accepted
2020-09-24 16:35:50
Documents
13
Period of Report
2020-09-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bgne-20200924.htm   iXBRL 8-K 56642
2 EX-10.1 ex101-restatedamendmen.htm EX-10.1 53358
  Complete submission text file 0001651308-20-000174.txt   306033

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20200924.xsd EX-101.SCH 2505
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bgne-20200924_cal.xml EX-101.CAL 793
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bgne-20200924_def.xml EX-101.DEF 8592
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20200924_lab.xml EX-101.LAB 30141
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20200924_pre.xml EX-101.PRE 21942
8 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20200924_htm.xml XML 11849
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 201195628
SIC: 2834 Pharmaceutical Preparations